Researchers Switch Off Brain Aging With a Nasal Spray

Key Takeaways:

• In a lab study, a nasal spray delivering extracellular vesicles (EVs) helped restore memory and brain cell function after aging-related decline.
• The treatment reduced chronic, low-grade inflammation in the brain by targeting key immune pathways.
• It also improved mitochondrial function, helping neurons regain energy and efficiency.
• Benefits appeared quickly and lasted for months after just two doses in the model system.
• The findings are early and preclinical, but suggest that some aspects of brain aging may be more reversible than once thought.

Brain aging is often framed as a slow, one-way process—gradual changes in memory, processing speed, and mental clarity over time. But new research from Texas A&M University suggests that some of these changes may be more flexible than they appear.

In a recent study, scientists tested a non-invasive approach designed to target one of the core features of brain aging: persistent, low-level inflammation. Using a nasal spray to deliver biologically active molecules directly to the brain, the team observed improvements in memory, cellular energy, and overall brain function in a laboratory model.

Targeting inflammation at the source

Aging brains often show a steady increase in baseline immune activity, sometimes referred to as “neuroinflammaging.” While subtle, this ongoing inflammation can influence how neurons communicate, adapt, and maintain themselves over time.

The researchers focused on calming this process using extracellular vesicles—tiny particles naturally released by cells that act as delivery vehicles for molecular signals.

These vesicles were loaded with microRNAs, which help regulate gene activity across multiple pathways. Once delivered, they targeted key inflammatory systems, including the NLRP3 inflammasome and cGAS-STING pathway—both known to amplify immune signaling in the brain.

By dialing down these pathways, the treatment appeared to shift the brain’s internal environment toward a more balanced, less reactive state.

A direct route to the brain

One of the most notable aspects of the study is how the therapy was delivered.

Rather than relying on systemic circulation, researchers used an intranasal approach. This allows compounds to bypass the blood–brain barrier and reach brain tissue more directly.

In practical terms, this method offers a non-invasive way to influence brain biology—something that has traditionally been difficult to achieve.

Restoring cellular energy

Beyond reducing inflammation, the treatment also affected how brain cells produce and use energy.

Mitochondria—often described as the cell’s energy generators—tend to become less efficient over time. This can leave neurons with fewer resources to maintain signaling, repair damage, and adapt to new information.

After treatment, researchers observed improved mitochondrial function, along with reductions in oxidative stress. Neurons appeared to regain some of their metabolic capacity, which may help explain the observed improvements in memory and cognition.

Measurable changes in memory

The biological findings were matched by functional improvements.

In behavioral tests, treated subjects showed stronger performance in tasks involving recognition and memory. They were better able to distinguish familiar from new objects and detect changes in their environment—key indicators of cognitive function.

Notably, these effects emerged after just two doses and persisted for an extended period, suggesting that even brief interventions may have lasting impact under the right conditions.

What this does and doesn’t show

This study was conducted in a controlled laboratory setting, and the results have not yet been tested in humans.

It also focuses on a specific mechanism—immune signaling and mitochondrial function—within a broader, highly complex process. Brain aging involves many interconnected systems, and no single intervention is likely to account for all of them.

Still, the findings are compelling as proof of concept. They suggest that targeting core biological pathways—like inflammation and cellular energy—may meaningfully influence how the brain ages.

A shift in how we think about brain aging

From a longevity perspective, this work points to a broader shift: aging may be less about fixed decline and more about modifiable biology.

Rather than viewing the brain as gradually losing function, this research frames it as a system that can, under certain conditions, regain balance and performance.

Future studies will need to determine how these findings translate to humans, how long the effects last, and which approaches are safest and most effective. But the central idea is already taking shape: Some aspects of brain aging may not just be slowed—but potentially reset.

References:

Leelavathi N. Madhu, Maheedhar Kodali, Shama Rao, Sahithi Attaluri, Raghavendra Upadhya, Goutham Shankar, Bing Shuai, Yogish Somayaji, Shruthi V. Ganesh, Vignesh S. Kumar, Jeswin E. James, Padmashri A. Shetty, Avery LeMaire, Xiaolan Rao, James J Cai, Ashok K. Shetty. Intranasal Human NSC‐Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS‐STING Signalling, in Aged Hippocampus. Journal of Extracellular Vesicles, 2026; 15 (2) DOI: 10.1002/jev2.70232